NanoViricides, Inc. Receives Additional Safety Data

WEST HAVEN, Conn.--(BUSINESS WIRE)--Dec. 5, 2005--NanoViricides, Inc. (Pink Sheets:NNVC), today announced that it has received additional laboratory data from the safety studies on the base polymer material. This data included blood test results as well as histological examinations of various organs. These new results confirm the original findings that the polymer used to construct its micelle caused no organic damage to the test animals. All results were within safe limits. Doses equivalent to 50X the expected human dose were used in the test.

MORE ON THIS TOPIC